POST-TRANSPLANTATION CYCLOPHOSPHAMIDE-BASED GVHD PROPHYLAXIS AFTER FLU-TBI MYELOABLATIVE CONDITIONING IS ASSOCIATED WITH FAVORABLE OUTCOMES IN ADULT PATIENTS WITH ALL TREATED WITH CONTEMPORARY INDUCTION REGIMENS

被引：0
|
作者：
Bambace, Nadia [1 ]
Linhares, Yuliya P. L. [1 ]
Perez, Ariel Perez [1 ]
Pharm, Tiba Al Sagheer [1 ]
Zahra, Talia [1 ]
Rubens, Muni B. [1 ]
机构：
[1] Miami Canc Inst, Miami, FL USA
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P166
引用
收藏
页码：265 / 266
页数：2
相关论文
共 13 条
  • [1] Prediction of non-relapse mortality in patients with AML and all receiving alloSCT in first CR with post-transplantation cyclophosphamide-based GVHD prophylaxis
    Hermans, S. J. F.
    Versluis, J.
    Labopin, M.
    Giebel, S.
    Van Norden, Y.
    Kulagin, A.
    Blaise, D.
    Diez Martin, J. L.
    Meijer, E.
    Rovira, M.
    Choi, G.
    Raiola, A. M.
    Koc, Y.
    Remenyi, P.
    Vydra, J.
    Kroeger, N.
    Sica, S.
    Martino, M.
    Van Gerkom, G.
    Chevallier, P.
    Busca, A.
    Herrera Arroyo, C.
    Brissot, E.
    Peric, Z.
    Nagler, A.
    Shouval, R.
    Ciceri, F.
    Cornelissen, J. J.
    Mohty, M.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 16 - 17
  • [2] Treatment-Responsive Acute Graft-versus-Host Disease after Post-Transplantation Cyclophosphamide-Based Prophylaxis: Incidence and Clinical Outcomes
    Herzog, Shannon
    Shanley, Ryan
    Holtan, Shernan G.
    MacMillan, Margaret L.
    Weisdorf, Daniel J.
    El Jurdi, Najla
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (07):
  • [3] Comparison of three TBI-based myeloablative conditioning regimens for allogeneic stem cell transplantation of adult patients with acute lymphoblastic leukemia (ALL)
    Eder, M.
    Dammann, E.
    Beutel, G.
    Ehrlich, S.
    Ritter, U.
    Stamer, K.
    Lueck, C.
    Gehoff, P.
    Schwarzer, A.
    Schuenemann, C.
    Diedrich, H.
    Schultze-Florey, C.
    Koenecke, C.
    Stadler, M.
    Ganser, A.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S438 - S438
  • [4] Extended Follow-up of Myeloablative, HLA-Matched Allogeneic BMT with High-Dose, Post-Transplantation Cyclophosphamide (PTCy) As Sole GVHD Prophylaxis: Favorable Outcomes Despite Low Incidence of Chronic GVHD
    Kanakry, Christopher G.
    Tsai, Hua-Ling
    Bolanos-Meade, Javier
    Smith, B. Douglas
    Gojo, Ivana
    Kasamon, Yvette L.
    Kanakry, Jennifer A.
    Zahurak, Marianna
    Fuchs, Ephraim J.
    Jones, Richard J.
    Luznik, Leo
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S37 - S37
  • [5] Outcomes after Bone Marrow Versus Peripheral Blood Haploidentical Hematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis
    Amin, Muhammad Kashif
    Shahzad, Moazzam
    Al-Ramahi, Joe S.
    DeJarnette, Shaun
    Lutfi, Forat
    Ahmed, Nausheen
    Abdelhakim, Haitham
    Bansal, Rajat
    Shune, Leyla
    Abdallah, Al-Ola
    Singh, Anurag K.
    Abhyankar, Sunil
    McGuirk, Joseph P.
    Mushtaq, Muhammad Umair
    [J]. BLOOD, 2023, 142
  • [6] Favorable Outcome of Post-Transplantation Cyclophosphamide Haploidentical Peripheral Blood Stem Cell Transplantation with Targeted Busulfan-Based Myeloablative Conditioning Using Intensive Pharmacokinetic Monitoring in Pediatric Patients
    Hong, Kyung Taek
    Kang, Hyoung Jin
    Choi, Jung Yoon
    Hong, Che Ry
    Cheon, Jung-Eun
    Park, June Dong
    Park, Kyung Duk
    Song, Sang Hoon
    Yu, Kyung-Sang
    Jang, In-Jin
    Shin, Hee Young
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (11) : 2239 - 2244
  • [7] Favorable outcome of post-transplantation cyclophosphamide haploidentical peripheral blood stem cell transplantation with a targeted busulfan-based myeloablative conditioning regimen using intensive pharmacokinetic monitoring for pediatric patients
    Hong, Kyung Taek
    Kang, Hyoung Jin
    Choi, Jung Yoon
    Hong, Che Ry
    Song, Sang Hoon
    Yu, Kyung-Sang
    Jang, In-Jin
    Shin, Hee Young
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 271 - 272
  • [8] Haploidentical transplantation using G-CSF-mobilized T-cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated with favorable outcomes
    P K Bhamidipati
    J F DiPersio
    K Stokerl-Goldstein
    A Rashidi
    F Gao
    G L Uy
    P Westervelt
    R Vij
    M A Schroeder
    C N Abboud
    J W Keller
    T A Fehniger
    R Romee
    [J]. Bone Marrow Transplantation, 2014, 49 : 1124 - 1126
  • [9] Haploidentical transplantation using G-CSF-mobilized T-cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated with favorable outcomes
    Bhamidipati, P. K.
    DiPersio, J. F.
    Stokerl-Goldstein, K.
    Rashidi, A.
    Gao, F.
    Uy, G. L.
    Westervelt, P.
    Vij, R.
    Schroeder, M. A.
    Abboud, C. N.
    Keller, J. W.
    Fehniger, T. A.
    Romee, R.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 (08) : 1124 - 1126
  • [10] Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor-Mobilized Donor Lymphocyte Infusions
    Jaiswal, Sarita Rani
    Zaman, Shamsuz
    Chakrabarti, Aditi
    Sen, Subrata
    Mukherjee, Shashwata
    Bhargava, Sneh
    Ray, Kunal
    O'Donnell, Paul V.
    Chakrabarti, Suparno
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1867 - 1873
12